Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Science Signaling|April 19, 2012
Synthetic signal propagation through direct cell-cell interactionMitsuhiro Matsuda, Makito Koga, Eisuke Nishida, et al.Nature Communications|February 6, 2015
Synthetic lateral inhibition governs cell-type bifurcation with robust ratiosMitsuhiro Matsuda, Makito Koga, Knut Woltjen, et al.Nature Communications|February 6, 2014
Foxd1 is a mediator and indicator of the cell reprogramming processMakito Koga, Mitsuhiro Matsuda, Teruhisa Kawamura, et al.Stem Cell Reports|October 7, 2015
Secreted Ephrin Receptor A7 Promotes Somatic Cell Reprogramming by Inducing ERK Activity ReductionJoonseong Lee, May Nakajima-Koyama, Masamitsu Sone, et al.Cancer Research Communications|December 16, 2024
The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric CancerShigehiro Koganemaru, Shohei Koyama, Fumitaka Suto, et al.Nature Communications|November 25, 2024
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.The Lancet. Oncology|August 8, 2024
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trialKanwal Raghav, Salvatore Siena, Atsuo Takashima, et al.Pageof 1